We use cookies to customise content for your subscription and for analytics. If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
On March 14, 2008, the U.S. Food and Drug Administration (FDA) announced that it had received approval from the State Department to establish offices in China
